Samin Ghanbari

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Zanjan University of Medical Sciences(Current)

University Hospitals of Cleveland

Case Western Reserve University

Binghamton University

Shahid Beheshti University of Medical Sciences

Samin Ghanbari is an author at Zanjan University of Medical Sciences specializing in coronary artery disease pharmacotherapy, coronary artery disease, and pharmacology.

Publications per year

2021–2023

Publications

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

Sepehr Gohari, Tara Reshadmanesh, Hadi Khodabandehloo et al. · Diabetology & Metabolic Syndrome · 2022 · 54 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Empagliflozin improves high-sensitive cardiac troponin-I and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD Trial

Homa Taheri, Hossein Chiti, Tara Reshadmanesh et al. · Journal of Diabetes & Metabolic Disorders · 2023 · 13 citations · Full text

Medicine, Cardiology, Pharmacology +16

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

Sepehr Gohari, Tara Reshadmanesh, Hadi Khodabandehloo et al. · BMC Cardiovascular Disorders · 2021 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–3 of 3